Abstract:Objective\r\nTo compare the diagnostic efficacy of transient elastography (TE) FibroScan and acoustic radiation force impulse imaging (ARFI) combined with serological models including aspartate aminotransferase-to-platelet ratio (APRI) and fibrosis-4 (FIB-4) in hepatitis B virus-related fibrosis.\r\n\r\n\r\nMethods\r\nSixty-seven patients with chronic HBV infection from October 2014 to May 2017 in Department of Infectious Diseases, Putuo Hospital were enrolled. Both FibroScan and ARFI were conducted in all patients together with serological tests. According to the golden standard of pathology results, the diagnosis values of FibroScan, ARFI combined with APRI or FIB-4 were compared as noninvasive assessment for liver fibrosis. Data with homogeneity of variance were tested by t test, and data with heterogeneity of variance were tested by Mann-Whitney U test.\r\n\r\n\r\nResults\r\nBased on the pathology results, the receiver operating characteristic (ROC) areas under the curve (AUC) of APRI, FIB-4, FibroScan and ARFI in diagnosis of hepatic fibrosis ≥S2 were 0.752, 0.612, 0.885, and 0.850, respectively. The AUC of ROC curve in diagnosis of hepatic fibrosis ≥S3 were 0.746, 0.733, 0.851, and 0.863, respectively. The AUC of ROC curve in diagnosis of hepatic fibrosis ≥S4 were 0.782, 0.705, 0.962 and 0.981, respectively. Combined liver imaging technique and serological tests, such as APRI with FibroScan, APRI with ARFI, FIB-4 with FibroScan or FIB-4 with ARFI, the AUC of ROC curve in the 4 groups in diagnosis of hepatic fibrosis ≥S2 were 0.887, 0.861, 0.893, and 0.853, respectively; in the diagnosis of hepatic fibrosis ≥S3 were 0.873, 0.871, 0.900, and 0.875, respectively; and in diagnosis of hepatic fibrosis ≥S4 were 0.952, 0.981, 0.969, and 0.981, respectively. FibroScan and ARFI were positively correlated with liver inflammation (r=0.467, P=0.000; r=0.371, P=0.002) and jaundice (r=0.424, P=0.000; r=0.0.312, P=0.01), while negatively correlated with platelet (r=-0.331, P=0.006; r=-0.312, P=0.01). The AUC of ROC curve of FibroScan, ARFI and their combination with serological model were significantly increased compared with the single serological model (all P\u003c0.05).\r\n\r\n\r\nConclusions\r\nSerological models such as APRI and FIB-4 as well as liver imaging techniques such as FibroScan and ARFI are all valuable in assessment of hepatic fibrosis, while FibroScan and ARFI have better diagnostic value. ARFI is convenient to application for its integration with the ordinary ultrasound system. The sensitivity and specificity for diagnosis of hepatic fibrosis could be improved by combining serological model with FibroScan or ARFI. Combination of APRI and ARFI show the highest accuracy in diagnosis of hepatic fibrosis. Combination of serological models and transient elastic liver imaging is recommended for assessment and follow-up of HBV-related fibrosis.\r\n\r\n\r\nKey words: \r\nFibroScan; Acoustic radiation force impulse imaging; APRI; FIB-4; Liver fibrosis

Evaluation of Hepatic Fibrosis and Portal Venous Pressure of Patients With Hepatitis B Using Real -time Tissue Elastography and Serological Indicators

The Diagnostic Value of the Fib-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis

The Value of Ultrasonic Elastographic Parameters in the Evaluation of Chronic Hepatitis B Liver Fibrosis

Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B.

Primary Study of Real-Time Tissue Elastography in Quantitative Diagnosis of Liver Fibrosis

Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection.

Evaluation of Liver Fibrosis and Portal Hypertension in Chronic Hepatitis B Patients by Acoustic Radiation Force Impulse Elastography

Determination of Serum Fibrosis Indexes in Patients with Chronic Hepatitis and Its Significance

A New Visual Transient Elastography Technique for Grading Liver Fibrosis in Patients with Chronic Hepatitis B.

Evaluation of serum non-invasive methods for the diagnosis of liver fibrosis in patients with chronic hepatitis B virus infection

Noninvasive Methods for Detecting Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B: A Single-Center Retrospective Study

Value of FibroScan in the Diagnosis of Progressive Liver Fibrosis in Patients with Chronic Hepatitis C and Related Influencing Factors

Diagnostic Value of Platelet Derived Growth Factor-Bb, Transforming Growth Factor-Beta 1, Matrix Metalloproteinase-1, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Serum and Peripheral Blood Mononuclear Cells for Hepatic Fibrosis

Clinical Study on the Liver Stiffness Value Measured by FibroScan and Aspartate Transaminase-to-platelet Ratio Index for Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis B

Diagnostic value of two liver imaging techniques combined with serological models for hepatitis B virus-related liver fibrosis

Value of real-time dual-mode elastography in diagnosis of liver fibrosis and inflammation in patients with chronic liver disease

Stiffness Value And Serum Biomarkers In Liver Fibrosis Staging: Study In Large Surgical Specimens In Patients With Chronic Hepatitis B

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C

Staging of Liver Fibrosis in Chronic Hepatitis B Patients with A Composite Predictive Model: A Comparative Study

Evaluation of hepatic injury in chronic hepatitis B and C using APRI and FIB-4 indices compared to fibroscan results

Assessing Liver Fibrosis in Chronic Hepatitis B Using MR Extracellular Volume Measurements: Comparison with Serum Fibrosis Indices